Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
Subscribe To Our Newsletter & Stay Updated